• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名日本男性的新型冠状病毒肺炎相关肺曲霉病:病例报告

COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report.

作者信息

Imoto Waki, Himura Hoshi, Matsuo Kenji, Kawata Sae, Kiritoshi Ayako, Deguchi Ryo, Miyashita Masahiro, Kaga Shinichiro, Noda Tomohiro, Yamamoto Katsumi, Yamada Koichi, Uchida Kenichiro, Nishimura Tetsuro, Yamamoto Hiromasa, Mizobata Yasumitsu, Kakeya Hiroshi

机构信息

Department of Infection Control Science, Osaka City University Graduate School of Medicine, 1-4-3, Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan; Department of Infectious Disease Medicine, Osaka City University Hospital, 1-5-7 Asahi-machi, Abeno-ku, Osaka, 545-8586, Japan; Department of Respiratory Medicine, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka, 545-8585, Japan.

Department of Traumatology and Critical Care Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan; Department of Trauma and Critical Care Center, Osaka City University Hospital, Osaka, Japan.

出版信息

J Infect Chemother. 2021 Jun;27(6):911-914. doi: 10.1016/j.jiac.2021.02.026. Epub 2021 Feb 25.

DOI:10.1016/j.jiac.2021.02.026
PMID:33674201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7906536/
Abstract

CAPA (COVID-19 associated pulmonary aspergillosis) is an important complication of COVID-19. It has been reported that the incidence of CAPA is as high as 19%-33% worldwide. However, its onset has not been reported in Japan. A 72-year-old Japanese man was diagnosed with COVID-19 and was transferred to our hospital due to deterioration of respiratory condition. Treatment with remdesivir, dexamethasone (DEXA), and antibiotics was performed under mechanical ventilation. Although the condition improved temporarily, a new shadow appeared in the lung, and Aspergillus fumigatus was cultured from sputum. The patient was clinically diagnosed with CAPA and treated with voriconazole. However, his progress deteriorated and he died. High-risk COVID-19 patients should be tested for Aspergillus to ensure early diagnosis of CAPA.

摘要

新型冠状病毒肺炎相关肺曲霉病(CAPA)是新型冠状病毒肺炎(COVID-19)的一种重要并发症。据报道,全球CAPA的发病率高达19%-33%。然而,日本尚未有其发病情况的报道。一名72岁的日本男性被诊断为COVID-19,因呼吸状况恶化被转至我院。在机械通气的情况下,使用瑞德西韦、地塞米松(DEXA)和抗生素进行治疗。尽管病情暂时有所改善,但肺部出现了新的阴影,痰培养出烟曲霉。该患者临床诊断为CAPA,并接受伏立康唑治疗。然而,他的病情恶化,最终死亡。高危COVID-19患者应进行曲霉检测,以确保CAPA的早期诊断。

相似文献

1
COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report.一名日本男性的新型冠状病毒肺炎相关肺曲霉病:病例报告
J Infect Chemother. 2021 Jun;27(6):911-914. doi: 10.1016/j.jiac.2021.02.026. Epub 2021 Feb 25.
2
COVID-19-Associated Pulmonary Aspergillosis, March-August 2020.2020年3月至8月与新型冠状病毒肺炎相关的肺曲霉病
Emerg Infect Dis. 2021;27(4):1077-1086. doi: 10.3201/eid2704.204895. Epub 2021 Feb 4.
3
COVID-19-associated pulmonary aspergillosis (CAPA) in Iranian patients admitted with severe COVID-19 pneumonia.伊朗重症 COVID-19 肺炎住院患者的 COVID-19 相关肺曲霉病 (CAPA)。
Infection. 2023 Feb;51(1):223-230. doi: 10.1007/s15010-022-01907-7. Epub 2022 Sep 15.
4
A fatal case report of invasive pulmonary aspergillosis and mucormycosis coinfection in an immunocompetent patient with coronavirus disease 2019 in Korea.韩国一名2019冠状病毒病免疫功能正常患者侵袭性肺曲霉病和毛霉病合并感染的致命病例报告。
Acute Crit Care. 2023 Aug;38(3):382-388. doi: 10.4266/acc.2021.01340. Epub 2022 Jun 27.
5
Successful treatment of proven coronavirus disease 2019-associated pulmonary aspergillosis with liposomal amphotericin B in a patient with bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后闭塞性细支气管炎综合征患者合并新型冠状病毒病 2019 相关肺曲霉病,使用脂质体两性霉素 B 成功治疗。
J Infect Chemother. 2023 Feb;29(2):223-227. doi: 10.1016/j.jiac.2022.10.020. Epub 2022 Nov 13.
6
Clinical characteristics of patients with coronavirus disease 2019-associated pulmonary aspergillosis on mechanical ventilation: A single-center retrospective study in Japan.COVID-19 相关机械通气相关性肺曲霉病患者的临床特征:日本单中心回顾性研究。
J Infect Chemother. 2023 Mar;29(3):239-243. doi: 10.1016/j.jiac.2022.11.001. Epub 2022 Nov 12.
7
Autopsy Findings of Severe COVID-19 Pneumonia Combined with Pulmonary Aspergillosis, Pneumothorax, and Pulmonary Thromboembolisms.COVID-19 重症肺炎合并肺曲霉病、气胸、肺血栓栓塞症的尸检结果。
Am J Case Rep. 2023 May 24;24:e939251. doi: 10.12659/AJCR.939251.
8
Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.新型冠状病毒肺炎相关肺曲霉病(CAPA)的发病率、诊断及转归:一项系统综述
J Hosp Infect. 2021 Jul;113:115-129. doi: 10.1016/j.jhin.2021.04.012. Epub 2021 Apr 21.
9
The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.囊性纤维化患儿肺曲霉病的临床表现——初步报告
Dev Period Med. 2015 Jan-Mar;19(1):66-79.
10
COVID-19-associated pulmonary aspergillosis: a prospective single-center dual case series.COVID-19 相关肺曲霉病:一项前瞻性单中心双病例系列研究。
Mycoses. 2021 Apr;64(4):457-464. doi: 10.1111/myc.13254. Epub 2021 Feb 16.

引用本文的文献

1
Characterization of Aspergillus spp. isolated from patients with coronavirus disease 2019.从 COVID-19 患者中分离的曲霉菌属的特性。
J Infect Chemother. 2023 Jun;29(6):580-585. doi: 10.1016/j.jiac.2023.02.001. Epub 2023 Feb 8.
2
Clinical characteristics of patients with coronavirus disease 2019-associated pulmonary aspergillosis on mechanical ventilation: A single-center retrospective study in Japan.COVID-19 相关机械通气相关性肺曲霉病患者的临床特征:日本单中心回顾性研究。
J Infect Chemother. 2023 Mar;29(3):239-243. doi: 10.1016/j.jiac.2022.11.001. Epub 2022 Nov 12.
3
Comparative risk assessment of COVID-19 associated mucormycosis and aspergillosis: A systematic review.

本文引用的文献

1
Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort.重症监护病房患者中与新冠病毒相关的肺曲霉病相关的危险因素:一项法国多中心回顾性队列研究
Clin Microbiol Infect. 2020 Dec 13;27(5):790.e1-5. doi: 10.1016/j.cmi.2020.12.005.
2
Coronavirus disease with multiple infarctions.伴有多处梗死的冠状病毒病
QJM. 2020 Dec 1;113(12):907-908. doi: 10.1093/qjmed/hcaa240.
3
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19.侵袭性曲霉病作为 COVID-19 中一种未被充分认识的二重感染
新型冠状病毒肺炎相关毛霉菌病和曲霉病的比较风险评估:一项系统评价
Health Sci Rep. 2022 Aug 18;5(5):e789. doi: 10.1002/hsr2.789. eCollection 2022 Sep.
4
Antifungal therapy in the management of fungal secondary infections in COVID-19 patients: A systematic review and meta-analysis.COVID-19 患者真菌感染的抗真菌治疗:系统评价和荟萃分析。
PLoS One. 2022 Jul 28;17(7):e0271795. doi: 10.1371/journal.pone.0271795. eCollection 2022.
5
Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review.新冠病毒合并感染患者的真菌感染:病例报告/病例系列概述与系统评价
Front Microbiol. 2022 Jul 6;13:888452. doi: 10.3389/fmicb.2022.888452. eCollection 2022.
6
Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis.新型冠状病毒肺炎相关肺曲霉病的临床及影像学特征
Diagnostics (Basel). 2022 May 11;12(5):1201. doi: 10.3390/diagnostics12051201.
7
Invasive Fungal Infections Complicating COVID-19: A Narrative Review.新型冠状病毒肺炎合并侵袭性真菌感染:一篇叙述性综述
J Fungi (Basel). 2021 Oct 29;7(11):921. doi: 10.3390/jof7110921.
8
COVID-19 and fungal infections: Etiopathogenesis and therapeutic implications.新型冠状病毒肺炎与真菌感染:发病机制与治疗相关性。
Rev Esp Quimioter. 2021 Sep;34 Suppl 1(Suppl1):72-75. doi: 10.37201/req/s01.21.2021. Epub 2021 Sep 30.
Open Forum Infect Dis. 2020 Jun 19;7(7):ofaa242. doi: 10.1093/ofid/ofaa242. eCollection 2020 Jul.
4
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.COVID-19 气管插管患者侵袭性肺曲霉病的流行病学:一项前瞻性研究。
Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614. doi: 10.1093/cid/ciaa1065.
5
Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis.应对和减轻 COVID-19 相关肺曲霉病的风险。
Eur Respir J. 2020 Oct 1;56(4). doi: 10.1183/13993003.02554-2020. Print 2020 Oct.
6
SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart.新型冠状病毒感染与心血管疾病:COVID-19 心脏。
Heart Lung Circ. 2020 Jul;29(7):973-987. doi: 10.1016/j.hlc.2020.05.101. Epub 2020 Jun 5.
7
COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment.新型冠状病毒肺炎相关肺曲霉病(CAPA)——从免疫学到治疗
J Fungi (Basel). 2020 Jun 24;6(2):91. doi: 10.3390/jof6020091.
8
COVID-19-associated pulmonary aspergillosis (CAPA) in patients admitted with severe COVID-19 pneumonia: An observational study from Pakistan.重症新型冠状病毒肺炎(COVID-19)患者中与COVID-19相关的肺曲霉病(CAPA):一项来自巴基斯坦的观察性研究。
Mycoses. 2020 Aug;63(8):766-770. doi: 10.1111/myc.13135. Epub 2020 Jul 18.
9
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.新型冠状病毒肺炎(COVID-19)重症患者中疑似侵袭性肺曲霉病的患病率。
Lancet Respir Med. 2020 Jun;8(6):e48-e49. doi: 10.1016/S2213-2600(20)30237-X. Epub 2020 May 20.
10
COVID-19-associated Pulmonary Aspergillosis.新型冠状病毒肺炎相关肺曲霉病
Am J Respir Crit Care Med. 2020 Jul 1;202(1):132-135. doi: 10.1164/rccm.202004-1038LE.